Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Greene

Showing results (1011-1020 of 1,094) with videos related to

Pageof 110
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomasJ V Lacey, L A Brinton, F M Abbas, et al.
Vaccine|May 5, 2018
Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumorsGarth S Herbert, Timothy J Vreeland, Guy T Clifton, et al.
Journal of Virology|January 29, 2011
Simian immunodeficiency virus SIVmac239Deltanef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaquesBenjamin J Burwitz, Zachary Ende, Benjamin Sudolcan, et al.
Journal of the American Chemical Society|October 25, 2024
Efficient Ground-State Recovery of UV-Photoexcited <i>p</i>-Nitrophenol in Aqueous Solution by Direct and Multistep PathwaysDeborin Ghosh, K Eryn Spinlove, Hallam J M Greene, et al.
Clinical Immunology (Orlando, Fla.)|March 26, 2018
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune responseTimothy J Vreeland, Jennifer K Litton, Na Qiao, et al.
Journal of the National Cancer Institute. Monographs|November 17, 2005
Race and ethnicity: comparing medical records to self-reportsCarmen N West, Ann M Geiger, Sarah M Greene, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2015
The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosisBojana Mirković, Gillian M Lavelle, Ahmed Abdul Azim, et al.
Science Translational Medicine|June 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancerNing Zhao, Stephanie O Peacock, Chen Hao Lo, et al.
Cancer Causes & Control : CCC|March 15, 2001
Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States)J V Lacey, M Frisch, L A Brinton, et al.
Retrovirology|July 6, 2014
Discovery and full genome characterization of a new SIV lineage infecting red-tailed guenons (Cercopithecus ascanius schmidti) in Kibale National Park, UgandaMichael Lauck, William M Switzer, Samuel D Sibley, et al.
Pageof 110

Showing results (1011-1020 of 1,094) with videos related to

Sort By:
Pageof 110
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 29, 1999
Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomasJ V Lacey, L A Brinton, F M Abbas, et al.
Vaccine|May 5, 2018
Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumorsGarth S Herbert, Timothy J Vreeland, Guy T Clifton, et al.
Journal of Virology|January 29, 2011
Simian immunodeficiency virus SIVmac239Deltanef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaquesBenjamin J Burwitz, Zachary Ende, Benjamin Sudolcan, et al.
Journal of the American Chemical Society|October 25, 2024
Efficient Ground-State Recovery of UV-Photoexcited <i>p</i>-Nitrophenol in Aqueous Solution by Direct and Multistep PathwaysDeborin Ghosh, K Eryn Spinlove, Hallam J M Greene, et al.
Clinical Immunology (Orlando, Fla.)|March 26, 2018
Phase Ib trial of folate binding protein (FBP)-derived peptide vaccines, E39 and an attenuated version, E39': An analysis of safety and immune responseTimothy J Vreeland, Jennifer K Litton, Na Qiao, et al.
Journal of the National Cancer Institute. Monographs|November 17, 2005
Race and ethnicity: comparing medical records to self-reportsCarmen N West, Ann M Geiger, Sarah M Greene, et al.
The Journal of Allergy and Clinical Immunology|September 22, 2015
The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosisBojana Mirković, Gillian M Lavelle, Ahmed Abdul Azim, et al.
Science Translational Medicine|June 28, 2019
Arginine vasopressin receptor 1a is a therapeutic target for castration-resistant prostate cancerNing Zhao, Stephanie O Peacock, Chen Hao Lo, et al.
Cancer Causes & Control : CCC|March 15, 2001
Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States)J V Lacey, M Frisch, L A Brinton, et al.
Retrovirology|July 6, 2014
Discovery and full genome characterization of a new SIV lineage infecting red-tailed guenons (Cercopithecus ascanius schmidti) in Kibale National Park, UgandaMichael Lauck, William M Switzer, Samuel D Sibley, et al.
Pageof 110